Global Generic drugs Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	168 Pages	TechNavio	March, 2024	INF18674281

Best Price Guarantee
Price	from $2,500
Length	168 Pages
Publisher	TechNavio
Published Date	March, 2024
SKU	INF18674281

Global Generic Drugs Market 2024-2028

The generic drugs market is forecasted to grow by USD 212.58 bn during 2023-2028, accelerating at a CAGR of 7.86% during the forecast period. The report on the generic drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by low-cost alternatives to branded medicines, increased outsourcing of drug discovery and development, and rising expiry of patents on branded drugs.

Technavio's generic drugs market is segmented as below:

By Route Of Administration

Oral
Injectables
Topical
Inhalers

By Type

Small-molecule generics
Biosimilars

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advent of RPA (robotic process automation) as one of the prime reasons driving the generic drugs market growth during the next few years. Also, rising m and a among market vendors and the emergence of hospital-owned generics will lead to sizable demand in the market.

The report on the generic drugs market covers the following areas:

Generic drugs market sizing
Generic drugs market forecast
Generic drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading generic drugs market vendors that include Abbott Laboratories, Amgen Inc., Amneal Pharmaceuticals Inc., Apotex Inc., Aspen Pharmacare Holdings Ltd, Aurobindo Pharma Ltd., Baxter International Inc., Biocon Ltd., Cadila Pharmaceuticals Ltd., Cipla Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Endo International Plc, Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Lupin Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., PlantForm Corporation, Sanofi SA, STADA Arzneimittel AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. Also, the generic drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary – Chart on Market Overview
  - Table Executive Summary – Data Table on Market Overview
  - Table Executive Summary – Chart on Global Market Characteristics
  - Table Executive Summary – Chart on Market by Geography
  - Table Executive Summary – Chart on Market Segmentation by Route of Administration
  - Table Executive Summary – Chart on Market Segmentation by Type
  - Table Executive Summary – Chart on Incremental Growth
  - Table Executive Summary – Data Table on Incremental Growth
  - Table Executive Summary – Chart on Vendor Market Positioning
Market Landscape
- Market ecosystem
  - Table Parent market
  - Table Market Characteristics
Market Sizing
- Market definition
  - Table Offerings of vendors included in the market definition
- Market segment analysis
  - Table Market segments
- Market size 2023
- Market outlook: Forecast for 2023-2028
  - Table Chart on Global - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Global - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Global Market: Year-over-year growth 2023-2028 (%)
  - Table Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Historic Market Size
- Global generic drugs market 2018 - 2022
  - Table Historic Market Size – Data Table on global generic drugs market 2018 - 2022 ($ billion)
- Route of administration Segment Analysis 2018 - 2022
  - Table Historic Market Size – Route of administration Segment 2018 - 2022 ($ billion)
- Type Segment Analysis 2018 - 2022
  - Table Historic Market Size – Type Segment 2018 - 2022 ($ billion)
- Geography Segment Analysis 2018 - 2022
  - Table Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
- Country Segment Analysis 2018 - 2022
  - Table Historic Market Size – Country Segment 2018 - 2022 ($ billion)
Five Forces Analysis
- Five forces summary
  - Table Five forces analysis - Comparison between 2023 and 2028
- Bargaining power of buyers
  - Table Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
- Bargaining power of suppliers
  - Table Bargaining power of suppliers – Impact of key factors in 2023 and 2028
- Threat of new entrants
  - Table Threat of new entrants – Impact of key factors in 2023 and 2028
- Threat of substitutes
  - Table Threat of substitutes – Impact of key factors in 2023 and 2028
- Threat of rivalry
  - Table Threat of rivalry – Impact of key factors in 2023 and 2028
- Market condition
  - Table Chart on Market condition - Five forces 2023 and 2028
Market Segmentation by Route of Administration
- Market segments
  - Table Chart on Route of Administration - Market share 2023-2028 (%)
  - Table Data Table on Route of Administration - Market share 2023-2028 (%)
- Comparison by Route of Administration
  - Table Chart on Comparison by Route of Administration
  - Table Data Table on Comparison by Route of Administration
- Oral - Market size and forecast 2023-2028
  - Table Chart on Oral - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Oral - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Oral - Year-over-year growth 2023-2028 (%)
- Injectables - Market size and forecast 2023-2028
  - Table Chart on Injectables - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Injectables - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Injectables - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Injectables - Year-over-year growth 2023-2028 (%)
- Topical - Market size and forecast 2023-2028
  - Table Chart on Topical - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Topical - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Topical - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Topical - Year-over-year growth 2023-2028 (%)
- Inhalers - Market size and forecast 2023-2028
  - Table Chart on Inhalers - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Inhalers - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Inhalers - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Inhalers - Year-over-year growth 2023-2028 (%)
- Market opportunity by Route of Administration
  - Table Market opportunity by Route of Administration ($ billion)
  - Table Data Table on Market opportunity by Route of Administration ($ billion)
Market Segmentation by Type
- Market segments
  - Table Chart on Type - Market share 2023-2028 (%)
  - Table Data Table on Type - Market share 2023-2028 (%)
- Comparison by Type
  - Table Chart on Comparison by Type
  - Table Data Table on Comparison by Type
- Small-molecule generics - Market size and forecast 2023-2028
  - Table Chart on Small-molecule generics - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Small-molecule generics - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Small-molecule generics - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Small-molecule generics - Year-over-year growth 2023-2028 (%)
- Biosimilars - Market size and forecast 2023-2028
  - Table Chart on Biosimilars - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Biosimilars - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Biosimilars - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Biosimilars - Year-over-year growth 2023-2028 (%)
- Market opportunity by Type
  - Table Market opportunity by Type ($ billion)
  - Table Data Table on Market opportunity by Type ($ billion)
Customer Landscape
- Customer landscape overview
  - Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Geographic Landscape
- Geographic segmentation
  - Table Chart on Market share by geography 2023-2028 (%)
  - Table Data Table on Market share by geography 2023-2028 (%)
- Geographic comparison
  - Table Chart on Geographic comparison
  - Table Data Table on Geographic comparison
- North America - Market size and forecast 2023-2028
  - Table Chart on North America - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on North America - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on North America - Year-over-year growth 2023-2028 (%)
  - Table Data Table on North America - Year-over-year growth 2023-2028 (%)
- Europe - Market size and forecast 2023-2028
  - Table Chart on Europe - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Europe - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Europe - Year-over-year growth 2023-2028 (%)
- Asia - Market size and forecast 2023-2028
  - Table Chart on Asia - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Asia - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Asia - Year-over-year growth 2023-2028 (%)
- Rest of World (ROW) - Market size and forecast 2023- 2028
  - Table Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- US - Market size and forecast 2023-2028
  - Table Chart on US - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on US - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on US - Year-over-year growth 2023-2028 (%)
  - Table Data Table on US - Year-over-year growth 2023-2028 (%)
- Germany - Market size and forecast 2023-2028
  - Table Chart on Germany - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on Germany - Year-over-year growth 2023-2028 (%)
  - Table Data Table on Germany - Year-over-year growth 2023-2028 (%)
- China - Market size and forecast 2023-2028
  - Table Chart on China - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on China - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on China - Year-over-year growth 2023-2028 (%)
  - Table Data Table on China - Year-over-year growth 2023-2028 (%)
- UK - Market size and forecast 2023-2028
  - Table Chart on UK - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on UK - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on UK - Year-over-year growth 2023-2028 (%)
  - Table Data Table on UK - Year-over-year growth 2023-2028 (%)
- India - Market size and forecast 2023-2028
  - Table Chart on India - Market size and forecast 2023-2028 ($ billion)
  - Table Data Table on India - Market size and forecast 2023-2028 ($ billion)
  - Table Chart on India - Year-over-year growth 2023-2028 (%)
  - Table Data Table on India - Year-over-year growth 2023-2028 (%)
- Market opportunity by geography
  - Table Market opportunity by geography ($ billion)
  - Table Data Tables on Market opportunity by geography ($ billion)
Drivers, Challenges, and Trends
- Market drivers
  - Low-cost alternatives to branded medicines
  - Increased outsourcing of drug discovery and development
  - Rising expiry of patents on branded drugs
- Market challenges
  - Rising credibility issues related to generic drugs
  - Increasing side effects in generic drugs
  - Stringent regulations
- Impact of drivers and challenges
  - Table Impact of drivers and challenges in 2023 and 2028
- Market trends
  - Advent of RPA (robotic process automation)
  - Rising M and A among market vendors
  - Emergence of hospital-owned generics
Vendor Landscape
- Overview
- Vendor landscape
  - Table Overview on Criticality of inputs and Factors of differentiation
- Landscape disruption
  - Table Overview on factors of disruption
- Industry risks
  - Table Impact of key risks on business
Vendor Analysis
- Vendors covered
  - Table Vendors covered
- Market positioning of vendors
  - Table Matrix on vendor position and classification
- Amgen Inc.
  - Table Amgen Inc. - Overview
  - Table Amgen Inc. - Product / Service
  - Table Amgen Inc. - Key offerings
- Aurobindo Pharma Ltd.
  - Table Aurobindo Pharma Ltd. - Overview
  - Table Aurobindo Pharma Ltd. - Product / Service
  - Table Aurobindo Pharma Ltd. - Key offerings
- Baxter International Inc.
  - Table Baxter International Inc. - Overview
  - Table Baxter International Inc. - Business segments
  - Table Baxter International Inc. - Key news
  - Table Baxter International Inc. - Key offerings
  - Table Baxter International Inc. - Segment focus
- Biocon Ltd.
  - Table Biocon Ltd. - Overview
  - Table Biocon Ltd. - Business segments
  - Table Biocon Ltd. - Key news
  - Table Biocon Ltd. - Key offerings
  - Table Biocon Ltd. - Segment focus
- Cadila Pharmaceuticals Ltd.
  - Table Cadila Pharmaceuticals Ltd. - Overview
  - Table Cadila Pharmaceuticals Ltd. - Product / Service
  - Table Cadila Pharmaceuticals Ltd. - Key offerings
- Cipla Ltd.
  - Table Cipla Ltd. - Overview
  - Table Cipla Ltd. - Business segments
  - Table Cipla Ltd. - Key news
  - Table Cipla Ltd. - Key offerings
  - Table Cipla Ltd. - Segment focus
- Dr Reddys Laboratories Ltd.
  - Table Dr Reddys Laboratories Ltd. - Overview
  - Table Dr Reddys Laboratories Ltd. - Business segments
  - Table Dr Reddys Laboratories Ltd. - Key offerings
  - Table Dr Reddys Laboratories Ltd. - Segment focus
- Fresenius SE and Co. KGaA
  - Table Fresenius SE and Co. KGaA - Overview
  - Table Fresenius SE and Co. KGaA - Business segments
  - Table Fresenius SE and Co. KGaA - Key news
  - Table Fresenius SE and Co. KGaA - Key offerings
  - Table Fresenius SE and Co. KGaA - Segment focus
- Merck and Co. Inc.
  - Table Merck and Co. Inc. - Overview
  - Table Merck and Co. Inc. - Business segments
  - Table Merck and Co. Inc. - Key news
  - Table Merck and Co. Inc. - Key offerings
  - Table Merck and Co. Inc. - Segment focus
- Novartis AG
  - Table Novartis AG - Overview
  - Table Novartis AG - Business segments
  - Table Novartis AG - Key news
  - Table Novartis AG - Key offerings
  - Table Novartis AG - Segment focus
- Pfizer Inc.
  - Table Pfizer Inc. - Overview
  - Table Pfizer Inc. - Product / Service
  - Table Pfizer Inc. - Key news
  - Table Pfizer Inc. - Key offerings
- Sanofi SA
  - Table Sanofi SA - Overview
  - Table Sanofi SA - Business segments
  - Table Sanofi SA - Key news
  - Table Sanofi SA - Key offerings
  - Table Sanofi SA - Segment focus
- Sun Pharmaceutical Industries Ltd.
  - Table Sun Pharmaceutical Industries Ltd. - Overview
  - Table Sun Pharmaceutical Industries Ltd. - Product / Service
  - Table Sun Pharmaceutical Industries Ltd. - Key news
  - Table Sun Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd.
  - Table Teva Pharmaceutical Industries Ltd. - Overview
  - Table Teva Pharmaceutical Industries Ltd. - Business segments
  - Table Teva Pharmaceutical Industries Ltd. - Key news
  - Table Teva Pharmaceutical Industries Ltd. - Key offerings
  - Table Teva Pharmaceutical Industries Ltd. - Segment focus
- Viatris Inc.
  - Table Viatris Inc. - Overview
  - Table Viatris Inc. - Business segments
  - Table Viatris Inc. - Key news
  - Table Viatris Inc. - Key offerings
  - Table Viatris Inc. - Segment focus
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
  - Table Inclusions checklist
  - Table Exclusions checklist
- Currency conversion rates for US$
  - Table Currency conversion rates for US$
- Research methodology
  - Table Research methodology
  - Table Validation techniques employed for market sizing
  - Table Information sources
- List of abbreviations
  - Table List of abbreviations